Anastomotic healing in a rat model of peritonitis after non-steroidal anti-inflammatory drug administration.
Anastomosis, Surgical
Anastomotic Leak
/ etiology
Animals
Anti-Inflammatory Agents, Non-Steroidal
/ pharmacology
Cecum
/ metabolism
Diclofenac
/ pharmacology
Inflammation
/ drug therapy
Ketorolac
/ pharmacology
Male
Matrix Metalloproteinase 9
/ metabolism
Peritonitis
/ metabolism
Rats, Wistar
Risk Factors
Surgical Wound Dehiscence
/ etiology
Wound Healing
/ drug effects
Journal
European journal of histochemistry : EJH
ISSN: 2038-8306
Titre abrégé: Eur J Histochem
Pays: Italy
ID NLM: 9207930
Informations de publication
Date de publication:
10 Jan 2020
10 Jan 2020
Historique:
received:
12
11
2019
accepted:
27
12
2019
entrez:
17
1
2020
pubmed:
17
1
2020
medline:
12
2
2020
Statut:
epublish
Résumé
The tissue inflammatory response can influence the outcome of anastomotic healing. Anastomotic leakage represents a dreadful complication after gastrointestinal surgery, in particular sepsis and intra-abdominal infections impair the restorative process of colic anastomoses. It has been debated whether the administration of non-steroidal anti-inflammatory drugs (NSAIDs) is a risk factor for dehiscence, since many patients receive NSAIDs in the early postoperative period. Our aim was, for the first time, to analyze the morpho-functional effects of postoperative administration of two commonly used NSAIDs, Diclofenac and Ketorolac, on the healing process of colo-colic anastomoses constructed under condition of fecal peritonitis in a rat model. Sixty adult male rats underwent two surgical procedures: peritonitis induction and colo-colic anastomosis, and were divided into three groups: 20 rats received saline; 20 rats 4 mg/kg Diclofenac and 20 rats 5 mg/kg Ketorolac. We assessed anastomosis strength, morphological features of tissue wound healing, immunohistochemical metalloproteinase 9 (MMP9) expression and collagen deposition and content by Sirius red staining and hydroxyproline level. We found no significant difference in bursting pressure, collagen content and organization and morphological features between the groups, except a significantly reduced presence of inflammatory cells and MMP9 expression in the groups treated with NSAIDs. Our findings showed that Diclofenac and Ketorolac administration did not affect post-surgical healing and did not increase the leakage risk of colo-colic anastomoses during peritonitis.
Identifiants
pubmed: 31941266
doi: 10.4081/ejh.2020.3085
pmc: PMC6985910
doi:
Substances chimiques
Anti-Inflammatory Agents, Non-Steroidal
0
Diclofenac
144O8QL0L1
Matrix Metalloproteinase 9
EC 3.4.24.35
Mmp9 protein, rat
EC 3.4.24.35
Ketorolac
YZI5105V0L
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Surgery. 2005 Feb;137(2):229-34
pubmed: 15674206
Microsurgery. 2006;26(3):131-6
pubmed: 16518804
Surg Res Pract. 2016;2016:4328089
pubmed: 27144224
Am J Surg. 1996 Jan;171(1):102-7; discussion 107-8
pubmed: 8554122
J Gastrointest Surg. 2014 Aug;18(8):1398-404
pubmed: 24912914
Metab Brain Dis. 2007 Dec;22(3-4):353-73
pubmed: 17828620
Colorectal Dis. 2010 Jul;12(7 Online):e93-8
pubmed: 19508511
Br J Surg. 2009 Jun;96(6):650-4
pubmed: 19434706
J Visc Surg. 2016 Aug;153(4):269-75
pubmed: 27480526
Br J Surg. 2001 Feb;88(2):228-34
pubmed: 11167872
BMJ. 2012 Sep 26;345:e6166
pubmed: 23015299
ANZ J Surg. 2005 Dec;75(12):1115-9
pubmed: 16398822
Int J Colorectal Dis. 2013 Aug;28(8):1151-9
pubmed: 23619615
J Int Med Res. 1996 Jul-Aug;24(4):352-7
pubmed: 8854289
Ann Surg. 2010 May;251(5):807-18
pubmed: 20395841
Int J Colorectal Dis. 2014 Dec;29(12):1507-16
pubmed: 25255850
Br J Surg. 2004 Dec;91(12):1613-8
pubmed: 15505871
JAMA Surg. 2015 Mar 1;150(3):223-8
pubmed: 25607250
Eur J Histochem. 2002;46(2):111-24
pubmed: 12152789
J Gastric Cancer. 2015 Sep;15(3):167-75
pubmed: 26468414
Br J Surg. 2003 Aug;90(8):981-8
pubmed: 12905552
Dis Colon Rectum. 1991 Mar;34(3):236-43
pubmed: 1999130
Br J Surg. 2012 May;99(5):721-7
pubmed: 22318712
Br J Surg. 2006 Apr;93(4):489-97
pubmed: 16521174
Eur Surg Res. 2013;50(1):24-31
pubmed: 23548268
Surgery. 2006 Jul;140(1):72-82
pubmed: 16857445
J Surg Res. 1980 Aug;29(2):189-201
pubmed: 6997619
Int J Colorectal Dis. 2013 Sep;28(9):1209-16
pubmed: 23397591
J Surg Res. 1997 Apr;69(1):81-6
pubmed: 9202651
Am J Surg. 2015 Aug;210(2):382-8
pubmed: 25890814
J Gastrointest Surg. 2013 Sep;17(9):1698-707
pubmed: 23690209
Br J Surg. 2015 Apr;102(5):462-79
pubmed: 25703524
Int J Colorectal Dis. 2011 Jun;26(6):737-46
pubmed: 21404056
PLoS One. 2018 Mar 22;13(3):e0194249
pubmed: 29566031
Int J Clin Exp Pathol. 2015 Jun 01;8(6):6126-34
pubmed: 26261490
Int J Surg. 2006;4(4):222-7
pubmed: 17462355
Eur Surg Res. 2012;48(2):73-8
pubmed: 22343935
J Leukoc Biol. 2005 Jul;78(1):279-88
pubmed: 15831558
Oncotarget. 2016 Jun 28;7(26):39582-39594
pubmed: 27074576
Mol Med Rep. 2014 Jun;9(6):2499-504
pubmed: 24718658